Impact of hyperbaric oxygenation on the efficiency of combined treatment for ovarian cancer
https://doi.org/10.17650/1994-4098-2014-0-1-81-84
Abstract
The author’s findings suggest the higher efficiency of standard combined treatment for ovarian cancer in combination with chemotherapy and oxygen therapy.
References
1. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;(1):18–23.
2. Тюляндин С.А., Носов Д.А., Переводчикова Н.И. Минимальные клинические рекомендации Европейского Общества Медицинской Онкологии (ESMO). М.: Издательская группа РОНЦ
3. им. Н.Н. Блохина, редакция русского перевода, 2010. 436 с.
4. Awada A., Klastersky J. Ovarian cancer: state of the art and future directions. Eur J Gynaecol Oncol 2004;25(6):673–6.
5. Dhillon P.K., Yeole B.B., Dikshit R. et al. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age-period-cohort analysis. Br J Cancer 2011;105(5):723–30. 5. World Health Organization. World health statistics. WHO Library Cataloguing-in- Publication Data, 2012. P. 43–79.
6. Ivanov S., Ivanov S., Khadzhiolov N. Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy. Akush Ginekol (Sofiia) 2004;43(6):17–9.
7. Rose P.G. Which is the best foot to put forward in recurrent ovarian cancer? Cancer 2012;118(13):3229–31.
8. Alagoz T., Buller R.E., Anderson B. et al. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 1995;75(9):2313–22.
9. Mueller-Klieser W., Schaefer C., Walenta S. et al. Assessment of tumor energy and oxygenation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res 1990;50(6):1681–5.
10. Vaupel P., Höckel M. Tumor oxygenation and its relevance to tumor physiology and treatment. Adv Exp Med Biol 2003;510:45–9. 11. Weinmann M., Belka C., Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004;27(1):83–90.
11. Cassileth B. Oxygen therapies. Oncology (Williston Park) 2009;23(13):1182.
12. ДзасоховА.С.Патогенетическое обоснование применения оксигенотерапии в онкологии. ВНМТ 2011;8(4):196.
13. Dar'ialovaS.L.,VedernikovaN.V.,BergutF.L., Zel'vin BM. Use of antitumor preparations under hyperbaric oxygenation in ovarian cancer. Akush Ginekol (Mosk) 1979;(12):34–6.
14. RusyniakD.E.,KirkM.A.,MayJ.D.etal. Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke 2003;34(2):571–4.
15. Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer – a review. Target Oncol 2012;7(4):233–42.
16. Guyot P., Ades A.E., Ouwens M.J., Welton N.J. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9.
Review
For citations:
Dzasokhov A.S. Impact of hyperbaric oxygenation on the efficiency of combined treatment for ovarian cancer. Tumors of female reproductive system. 2014;(1):81-84. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-1-81-84
Views:
548
Email this article 